MY PUBLICATIONS I

The following are my published articles in international journals.

 

MY PUBLICATIONS I

 

1]    Abbas FM, Julie BM, Sharma A, Halawa A. “Contrast nephropathy” in renal transplantation: Is it real? World J Transplant 2016; 6 (4): 682-688 https://www.wjgnet.com/2220-3230/full/v6/i4/682.htm

Summery: One of the greatest risks on the human kidney is the exposure of the human kidney to the contrast material. This risk will be augmented in the presence of diabetes mellitus and dehydration. Many therapeutic options have been suggested, but unfortunately, the optimum option still uncertain.

2]    Abbas F, El Kossi M, Jin JK, Sharma A, Halawa A. De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases? World J Transplant 2017; 7(6): 285-300

https://www.wjgnet.com/2220-3230/full/v7/i6/285.htm

 

Summary: With the presence of good history in the preparation of a kidney transplant, we can diagnose that this disease that affecting the implanted graft is a new one i.e. de novo GN (glomerular) disease. This is to a great extent depends on the presence of enough data documenting the absence of any data related to the new GN disease.

 

3] Abbas F, El Kossi M, Jin JK, Sharma A, Halawa A. Recurrence of primary glomerulonephritis: Review of the current evidence. World J Transplant 2017; 7(6): 301-316    https://dx.doi.org/10.5500/wjt.v7.i6.301

Summery: Kidney transplantation has been approved as the best therapeutic option for ESRD (end stage renal disease). Unfortunately, the risk of recurrence of the native kidney disease is a major risk for failure of the new implanted graft. The list of recurrent kidney diseases has been discussed. Not all the kidney diseases are vulnerable for recurrence and the therapeutic approach of these recurrent diseases will be slightly different.  

4]    Abbas F, El Kossi M, Kim JJ, Sharma A, Halawa A. Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease. World J Transplantation 2018; 8(5): 122-141 https://www.wjgnet.com/2220-3230/full/v8/i5/122.htm

 

Summary: Thrombotic microangiopathy (TMA) is a serious disease endangering the survival of the kidney allograft. Early recognition of this disease is mandated for a better TMA management. The role genetic studies have been recently elucidated. The recently admitted, complement blocker agents has been approved to play a fundamental role of this devastating disease. This will be definitely reflected on the kidney allograft longevity.

5]    Abbas F, El Kossi M, Kim JJ, Shaheen IS, Sharma A, Halawa A. Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in de novo and recurrent diseases. World J Transplantation 2018; 8(6): 203-219 https://www.wjgnet.com/2220-3230/full/v8/i6/203.htm

Summary: The advent of complement blocker agents has been clearly successful in the control of serious and resistant diseases that could be attributed to many genetic mutations (alterations). The observed benefits of these curative agents not only curative for these group of diseases but also have a preventive role against post-transplant recurrence of complement-related diseases.

6]    Fedaey Abbas, Mohsen El Kossi, Jon Jin Kim, Ihab Sakr Shaheen, Ajay Sharma, Ravi Pararajasingam and Ahmed Halawa.  Management of Diabetic Patient with CKD 5 and Progressive Diabetic Complications: A Case-Based Review. World Journal of Transplantation. J of Transplantation science.

https://www.scitcentral.com/article.php?journal=66&article=615&article_title=Management%20of%20Diabetic%20Patient%20with%20CKD%205%20and%20Progressive%20Diabetic%20Complications:%20A%20Case-Based%20 Review

 

Summary: Diabetes mellitus is a vascular disease. Old-standing diabetic patients are vulnerable for many complications, particularly so, in poorly controlled diabetic patients. An offered pancreatic graft life span up to 14 years, this lady- in our case- can gain a double benefit of SKP (simultaneous Kidney-pancreatic) transplantation. However, in view of the current shortage of a cadaveric donor transplant, an offered living related donor kidney would be a reasonable therapeutic choice in absence of a direct contraindication. On the other hand, PAK (pancreatic after kidney) transplant as well as Islets after kidney transplant may be an alternate approach. However, pancreatic alone or Islets transplant alone would be inappropriate options owing to the possibility of developed sensitivity. The latter might impede any future chance of transplantation.

 

7]    Abbas F, El Kossi M, Kim JJ, Shaheen IS, Sharma A, Pararajasingam R, Halawa A. Parasitic infestation in organ transplant recipients: a comprehensive review in the absence of robust evidence. J Egypt Soc Nephrol Transplant [serial online] 2019 [cited 2019 Jun 12]; 19:31-61. Available from: http://www.jesnt.eg. net/text. asp? 2019/19/2/31/260214

 

 

 

Summary: In view of the widespread extension of organ transplant centres all over the world and the expansion of transplant tourism, the possibility of transmission of parasitic infection is currently increasing. Furthermore, awareness of this type of infection is gaining more interest. Some of these parasites are related to endemic infestation, while other are more related to the source of donation, i.e. the donated organ. The recent progress, however, in diagnosing these types of infestations as well as the advancement in serology and microbiology may allow limitations of the possibility of parasitic transmission whatever the source originating from. Both the transplant recipient and his/her clinician should be aware of this unique type of infection.

 

8]    Abbas F, El Kossi M, Shaheen IS, Sharma A, Halawa A. Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches. World J Transplant 2020; 10(2): 29-46. https://www.wjgnet.com/2220-3230/full/v10/i2/29.ht 10.5500/ wjt.v10.i2.29

Summary: One of the most serious complications after kidney transplantation is the development of malignancy of the lymphatic system. An augmented immunosuppressive load is usually the culprit agent. Moreover, re-transplantation can be- despite rare- associated with recurrence of this type of malignancy. The recent progress on genomic technology has its impact of this serious disease. An increased awareness of the manifestations of this complication is necessary for a timely diagnosis and proper management. Furthermore, close liaison between nephrology and hemato-oncology teams will be reflected on the better control of this type of cancer.

 

9]    Books: My first “book”: “Seven Hundred Questions and Answers in Nephrology, Dialysis and Transplantation: “794” Questions with model answers in Clinical Nephrology, Dialysis and Transplantation, 400 pages enriched with many histopathologic slides and radiographic pictures were supplied. The book is dealing with various clinical problems in clinical nephrology, hemodialysis and kidney transplantation associated with model answers. (مكتبة "المريخ"- جده والرياض KSA"(.

10] Second book, (in press): “Renal Face” clinical scenarios for diagnosis of kidney diseases via checking facial lesions in a patient with kidney disease.

                                {With Prof Dr “Abdol Majid Nahass”, Sheffield, UK}.